Neuronal degeneration linked to apoptosis can be inhibited by a family of proteins known as inhibitors of apoptosis proteins (IAPs). We examined three members of the IAP family that are implicated in the regulation of neuronal death. We assessed NAIP, XIAP, and cIAP-2 protein levels in the entorhinal cortex of non-demented, cognitively impaired and Alzheimer's disease cases. Levels of paired helical filament-1 (PHF-1), a marker of neurofibrillary tangles, were assessed to determine their relationship to IAP levels. NAIP was decreased in AD cases compared to mildly impaired and unimpaired cases, and this decrease was associated with increased PHF-1 levels. Low NAIP levels were associated with higher Braak and Braak tangle stage and cognitive dysfunction. XIAP levels were higher in AD cases and cIAP-2 levels did not vary with clinical status. Our data suggest that decreased NAIP may place neurons at risk for the development of tangles and apoptosis.
Introduction
Alzheimer's disease (AD) is characterized by a progressive accumulation of extracellular β-amyloid (Aβ) in the form of senile plaques and intracellular tau in the form of neuropil threads and neurofibrillary tangles (NFTs). In addition, neuronal and synaptic loss occur during the progression of AD (for reviews, see Cotman, 1998; Mattson, 2004) , and this degeneration is linked to the presence of Aβ plaques (Allen et al., 2001; Song et al., 2006; Takuma et al., 2004) and NFTs (Broe et al., 2001, and reviewed in Dickson, 2004; Gomez-Isla et al., 1997; Rohn et al., 2002b) .
Recent evidence suggests that neuronal degeneration and loss in AD may result in part from the activation of apoptotic-related pathways or apoptosis itself. In AD and other neurodegenerative disorders, neurons induce a series of proteases including caspases, a class of cysteine proteases, which are key molecules in the execution of apoptosis (reviewed in Prunell and Troy, 2004) . Caspases act to either initiate (initiator caspases) or advance (executioner caspases) apoptosis and result in the characteristic morphological changes of cell death such as shrinkage, nuclear fragmentation, and membrane blebbing. Activated initiator and effector caspases are elevated in the brains of AD patients (Guo et al., 2004; Rohn et al., 2001 Rohn et al., , 2002a Su et al., 2001 Su et al., , 2002 Zhao et al., 2003) and exhibit a high degree of co-localization with NFTs, granulovacuolar degeneration, and dystrophic neurites (Guo et al., 2004; Newman et al., 2005; Rissman et al., 2004; Rohn et al., 2001 ). An accumulation of caspase cleavage products including cleaved cytoskeletal proteins (e.g., actin, spectrin, tau), amyloid precursor protein (APP), glial fibrillary acidic protein (GFAP), and poly (ADP-ribose) polymerase (PARP) (for reviews, see Marks and Berg, 1999; Rohn et al., 2002b) is also found in the AD brain.
Caspase activation may provide a mechanistic link between Aβ and NFT pathologies in AD (Cotman et al., 2005) . In the AD brain, Aβ plaques co-localize with cells showing classical apoptotic morphology and caspase activation (reviewed in Cotman et al., 2005) . This is consistent with in vitro studies showing that aggregated Aβ triggers caspase-dependent apoptosis (Lesne et al., 2005; Loo et al., 1993) . Several recent studies report that Aβ-mediated caspase activation may contribute to the development of tangle pathology and neuronal compromise. Caspase-cleaved tau co-localizes with intracellular Aβ, activated caspase-3, and paired helical filament-1 (PHF-1), a marker of mature tangle pathology, and is detected in patients with mild cognitive impairment but not within control brains, suggesting that caspase cleavage of tau may occur early in the progression of AD (Rissman et al., 2004) . Consistent with this hypothesis, Aβ exposure leads to the formation of paired helical tau-like filaments in vitro (Ferrari et al., 2003; Gamblin et al., 2003) , which occurs via Aβ's activation of caspases (Ivins et al., 1999; Loo et al., 1993 ) that in turn cleave
